Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Spinal Cord Stimulation Market Growth in 2025?

The market for spinal cord stimulation has seen robust growth in recent years. The market is forecasted to rise from $3.14 billion in 2024 to $3.42 billion in 2025, boasting a compound annual growth rate (CAGR) of 8.8%. The historical growth can be credited to factors such as an aging demographic, a rise in chronic pain prevalence, increased awareness about spinal cord stimulation, and a growing preference for non-invasive pain control methods.

What Is the Forecast for the Spinal Cord Stimulation Market Size Through 2029?

In the coming years, the spinal cord stimulation market is predicted to experience considerable growth, expanding to a value of $4.78 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. This growth during the forecast duration can be credited to the creation of innovative stimulation treatments, broader uses for spinal cord stimulation, increased demand for less invasive procedures, escalated research and development investments, and favorable reimbursement policies. Key trends for the forecast duration include the incorporation of artificial intelligence into spinal cord stimulation devices, the development of non-parasthesia-based stimulation, efforts to increase market visibility in budding economies, the use of rechargeable stimulators, and the prioritization of patient-focused strategies in product creation.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12180&type=smp

What are the Key Market Players in Spinal Cord Stimulation Market and How They’re Evolving?

Major companies operating in the spinal cord stimulation market include Abbott Laboratories, Medtronic PLC, Stryker Corporation, Boston Scientific Corp., LivaNova PLC, Globus Medical Inc., ZimVie Inc., Avanos Medical Inc. , Nevro Corp., Axonics Modulation Technologies Inc., SPR Therapeutics Inc., BlueWind Medical, Bioness Inc., Saluda Medical Pty. Ltd., Soterix Medical Inc., Synapse Biomedical Inc., NeuroMetrix Inc., NDI Medical LLC, Neuros Medical Inc., Cirtec Medical Corp., Mainstay Medical International plc, Gimer Medical

What Are the Primary Growth Drivers in the Spinal Cord Stimulation Market?

The growth of the spinal cord stimulation market is anticipated to be driven by the rising occurrence of spinal cord injuries. Such injuries involve damage to the spinal cord or the nerves at the end of the spinal canal, which typically result from traumatic incidents and home accidents. Spinal cord stimulation, which administers low-voltage electricity to the spinal cord to mitigate pain, is the treatment method for these injuries. For example, in May 2022, data from the National Library of Medicine, a US government library, indicated that 250,000 to 500,000 people across the globe are impacted by spinal cord injuries on a yearly basis. In the US alone, approximately 17,000 new cases are reported each year, with an estimated 282,000 Americans living as survivors of spinal cord injury. Thus, the growing incidence of spinal cord injuries is stimulating the expansion of the spinal cord stimulation market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12180&type=smp

What Are the Leading Segments in the Global Spinal Cord Stimulation Industry?

The spinal cord stimulation market covered in this report is segmented –

1) By Product: Rechargeable, Non-rechargeable

2) By Application: Failed Back Surgery Syndrome (FBSS), Degenerative Disc Disease (DDD), Complex Regional Pain Syndrome (CRPS), Arachnoiditis, Other Disease Indications

3) By End User: Hospitals, Ambulatory Surgery Centers, Specialty Clinics

Subsegments:

1) By Rechargeable: Implantable Pulse Generators (IPGs), Rechargeable Lead Systems

2) By Non-Rechargeable: Non-Rechargeable Implantable Pulse Generators (IPGs), Non-Rechargeable Lead Systems

What Are the Key Market Trends in the Spinal Cord Stimulation Industry?

Technological advancements are increasingly becoming a prominent trend in the spinal cord stimulation market. A primary strategy for key companies in the sector is to innovate advanced technological solutions in order to maintain their market dominance. For instance, in December 2022, Abbott Laboratories, an American medical device establishment, introduced the Eterna spinal cord stimulation system for chronic treatment into the market. This product is currently the smallest implantable, rechargeable spinal cord stimulator available for chronic pain management. The Eterna SCS uses Abbott’s low-dose BurstDR stimulation, recognized as the only SCS waveform technology with the highest level of clinical evidence, class 1A. It has been revealed to provide a pain relief efficiency that’s 23% higher than traditional waveform technology methods.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/spinal-cord-stimulation-global-market-report

What Is the Regional Outlook for the Spinal Cord Stimulation Market?

North America was the largest region in the spinal cord stimulation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the spinal cord stimulation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12180

This Report Delivers Insight On:

1. How big is the spinal cord stimulation market, and how is it changing globally?

2. Who are the major companies in the spinal cord stimulation market, and how are they performing?

3. What are the key opportunities and risks in the spinal cord stimulation market right now?

4. Which products or customer segments are growing the most in the spinal cord stimulation market?

5. What factors are helping or slowing down the growth of the spinal cord stimulation market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model